Tesamorelin is a synthetic 44‑amino acid peptide analog of human growth hormone‑releasing hormone (GHRH). It is a potent and selective agonist of the GHRH receptor, stimulating the synthesis and secretion of endogenous growth hormone from the pituitary somatotrophs. Tesamorelin has been extensively characterized in biochemical and cellular research as a tool for studying the GHRH‑GH‑IGF‑1 axis. This 10mg format is supplied as a lyophilized (freeze‑dried) powder for reconstitution and use in in‑vitro laboratory applications.
| Parameter | Specification |
| Molecular Formula | C₂₂₁H₃₆₆N₇₂O₆₆S |
| Molecular Weight | ~5135.8 g/mol |
| Purity | ≥99% (by HPLC) |
| Amino Acid Sequence | H‑Tyr‑Ala‑Asp‑Ala‑Ile‑Phe‑Thr‑Asn‑Ser‑Tyr‑Arg‑Lys‑Val‑Leu‑Gly‑Gln‑Leu‑Ser‑Ala‑Arg‑Lys‑Leu‑Leu‑Gln‑Asp‑Ile‑Met‑Ser‑Arg‑Gln‑Gln‑Gly‑Glu‑Ser‑Asn‑Gln‑Glu‑Arg‑Gly‑Ala‑Arg‑Ala‑Arg‑Leu‑NH₂ |
- In‑vitro studies of growth hormone‑releasing hormone (GHRH) receptor activation and downstream signaling pathways.
- Research into the regulation of the GHRH‑GH‑IGF‑1 axis and its role in cellular metabolism and proliferation.
- Cell culture supplementation (in‑vitro only) for investigating somatotroph function and growth hormone secretion.
- Reference standard in analytical method development.
This product is sold strictly for laboratory research purposes only. It is not a drug, medicine, or medical device. Not for human or animal use, consumption, or administration. Not for diagnostic, therapeutic, or clinical applications. Not for use in food or cosmetics. By purchasing, you confirm that you are at least 21 years of age and affiliated with a qualified research institution or laboratory.
